Merck Mayo AI Partnership Aims To Sharpen Drug Discovery Decisions
Merck (NYSE:MRK) and Mayo Clinic announced a new research and development partnership focused on using artificial intelligence and multimodal clinical...
Last updated: 2026-02-19 16:29:13 ET
No hourly mention data available.
Merck (NYSE:MRK) and Mayo Clinic announced a new research and development partnership focused on using artificial intelligence and multimodal clinical...
The PD-1 and PD-L1 inhibitors market offers significant opportunities by expanding cancer treatment options using immunotherapy. Key developments incl...
The atopic dermatitis market offers opportunities in developing new and innovative therapies, with over 100 companies and 110 drugs in various stages ...
Opportunities in the Sickle Cell Disease market include advancing gene-editing therapies like EDIT-301, expanding VOC-reducing treatments such as incl...
First National Bank of Omaha bought a new stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) in the third quarter, according to the compan...
The FDA reversed course and told Moderna it would review its application for a new flu vaccine, after refusing to do so earlier this month
Pfizer (NYSE:PFE) reported positive topline results from its pivotal BREAKWATER trial. The study evaluated a BRAFTOVI based combination in previously ...
Rentec Direct, an Oregon-based property management software company serving clients nationwide, is celebrating the 10th anniversary of its Tech Master...
The rheumatoid arthritis market is poised for growth due to the rising adoption of advanced disease-modifying therapies, fostering deeper patient rete...
Roche Holding (SWX:ROG) reported positive Phase III MAJESTY trial results for Gazyva in primary membranous nephropathy. The company announced Gazyva a...